[go: up one dir, main page]

ES2077584T3 - Antibioticos glicopeptidos. - Google Patents

Antibioticos glicopeptidos.

Info

Publication number
ES2077584T3
ES2077584T3 ES89310745T ES89310745T ES2077584T3 ES 2077584 T3 ES2077584 T3 ES 2077584T3 ES 89310745 T ES89310745 T ES 89310745T ES 89310745 T ES89310745 T ES 89310745T ES 2077584 T3 ES2077584 T3 ES 2077584T3
Authority
ES
Spain
Prior art keywords
vancosaminyl
epi
alpha
disaccharide
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89310745T
Other languages
English (en)
Inventor
Manuel Debono
Robert Michael Molloy Sr
Ramakrishnan Nagarajan
Amelia Apolinaria Schabel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2077584T3 publication Critical patent/ES2077584T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

SE PREPARAN COMPUESTOS CICLOPEPTIDA RELACIONADOS CON A82846 MEDIANTE TRATAMIENTO DE UN ANTIBIOTICO SELECCIONADO DE ENTRE COMPONENTES A,B Y C A82846 CON ACIDO TRIFLUOROACETICO PARA ELIMINAR 1) EL GRUPO (ALFA)-L-O-4-EPI-VANCOSAMINIL UNIDO AL DISACARIDO; 2) EL GRUPO DISACARIDO ((ALFA)-L-O-4-EPI-VANCOSAMINIL-(BETA)-O-GLUCOSIL) O 3) AMBOS EL GRUPO DISACARIDO Y EL GRUPO (ALFA)-L-O-4-EPI-VANCOSAMINIL UNIDO AL NUCLEO PEPTIDO DE ESTOS ANTIBIOTICOS. LOS COMPUESTOS TIENEN ACTIVIDAD ANTIBACTERIANA, ESPECIALMENTE CONTRA MICROORGANISMOS GRAM-POSITIVOS.
ES89310745T 1988-10-19 1989-10-19 Antibioticos glicopeptidos. Expired - Lifetime ES2077584T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25967888A 1988-10-19 1988-10-19

Publications (1)

Publication Number Publication Date
ES2077584T3 true ES2077584T3 (es) 1995-12-01

Family

ID=22985922

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89310745T Expired - Lifetime ES2077584T3 (es) 1988-10-19 1989-10-19 Antibioticos glicopeptidos.

Country Status (8)

Country Link
US (1) US6111067A (es)
EP (1) EP0365319B1 (es)
JP (1) JP2854343B2 (es)
AT (1) ATE126807T1 (es)
CA (1) CA1339808C (es)
DE (1) DE68923928T2 (es)
ES (1) ES2077584T3 (es)
GR (1) GR3017211T3 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
PE40996A1 (es) * 1994-01-28 1996-10-14 Lilly Co Eli Derivado de antibiotico de glucopeptido
PT836619E (pt) * 1995-07-05 2004-11-30 Aventis Bulk S P A Purificacao de antibioticos dalba-heptidicos por focagem isoelectrica
US5919756A (en) * 1996-06-28 1999-07-06 Eli Lilly And Company Amides
CA2497159A1 (en) * 2002-08-30 2004-03-11 K.U. Leuven Research And Development Glycopeptide antibiotic and semisynthetic derivatives thereof and their use as antiviral agents
US7632918B2 (en) 2005-02-28 2009-12-15 Novartis Vaccines And Diagnostics, Inc. Semi-synthetic glycopeptides with antibiotic activity
GB2449156B8 (en) * 2007-05-08 2010-06-02 Lead Therapeutics Inc Semi-synthetic glycopeptides with antibacterial activity.
CN101928331B (zh) * 2009-06-26 2014-05-28 上海来益生物药物研究开发中心有限责任公司 一种化合物及其应用
CN102690330B (zh) * 2011-03-23 2014-10-08 浙江医药股份有限公司新昌制药厂 三取代糖肽类衍生物及药物组合物、以及其制备方法和用途
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029769A (en) * 1976-05-24 1977-06-14 Eli Lilly And Company Antibiotic A-35512B aglycone
US4322343A (en) * 1980-12-18 1982-03-30 Eli Lilly And Company Pseudo-aglycone of actaplanin
US4552701A (en) * 1984-04-16 1985-11-12 Eli Lilly And Company Glycopeptide antibiotics and process of preparation
US4946941A (en) * 1986-01-24 1990-08-07 Shionogi & Co., Ltd. Novel glycopeptide antibiotics
JPS62174099A (ja) * 1986-01-24 1987-07-30 Shionogi & Co Ltd 新規グリコペプチド系抗生物質ｐａ−４２８６７−ａおよびｐａ−４２８６７−ｂとその製造方法
EG18377A (en) * 1986-09-19 1993-04-30 Lilly Co Eli Process for preparing glycopeptide antibiotics
EP0273727A3 (en) * 1986-12-30 1990-01-17 Smithkline Beecham Corporation Glycosylated glycopeptides
US5071749A (en) * 1987-04-16 1991-12-10 Shionogi & Co., Ltd. Glycopetide antibiotic pa-45052-b

Also Published As

Publication number Publication date
US6111067A (en) 2000-08-29
CA1339808C (en) 1998-04-07
DE68923928T2 (de) 1996-02-08
EP0365319A2 (en) 1990-04-25
DE68923928D1 (de) 1995-09-28
EP0365319A3 (en) 1990-10-03
ATE126807T1 (de) 1995-09-15
JPH02209893A (ja) 1990-08-21
GR3017211T3 (en) 1995-11-30
EP0365319B1 (en) 1995-08-23
JP2854343B2 (ja) 1999-02-03

Similar Documents

Publication Publication Date Title
CA2031803A1 (en) Improvements in or relating to glycopeptide deriveratives
PH24288A (en) Glycopeptide antibiotics a82846
RU93050124A (ru) Новые производные эритромицина, метод их получения и фармацевтическая композиция на их основе
CS845583A2 (en) Zpusob pripravy 4 ep homoerythromycinu a
EP0679163A4 (en) FACTOR-3 OF GROWTH AND DIFFERENTIATION.
CA2184886A1 (en) Method of strengthening antibacterial action of antibiotics
GB8307847D0 (en) Antibiotics l 17054 and l 17046
GB8811760D0 (en) Antibiotic
ES2077584T3 (es) Antibioticos glicopeptidos.
ES2010729A6 (es) Un procedimiento para prerparar un des-acil- antibiotico a 40926.
NZ216231A (en) Process for preparing the antibiotic complex "teicoplanin" using actinoplanes teichomyceticus
IN167138B (es)
FI931452A (fi) Nya 9-fluor-7-oxo-7h-pyrido(1,2,3-de)(1,4)bensoxazin-6-karboxylsyror och -estrar
EP0287110A3 (en) Glycopeptide antibiotics pa-45052
DE59207033D1 (de) Balhimycin-abgeleitete glykopeptidische Antibiotika
ES2059443T3 (es) Derivados de antibioticos del tipo de la teicoplanina.
GR3005464T3 (es)
CA2014486A1 (en) Antitumor and antibacterial substituted disulfide derivatives prepared from compounds possessing a methyltrithio group
JPS51139692A (en) Process for preparing a new antibiotic substance ta-146
NO930834L (no) Anvendelse av et 2-deoksystreptamin-type antibiotikum
DE69012942D1 (de) Glycopeptid-Antibiotika.
GB9009963D0 (en) Glycopeptide antibiotic
AR244343A1 (es) Procedimiento para preparar el antibiotico vancomicina por via microbiologica de fermentacion aerobia
IT8620974A0 (it) Antifungina, sua preparazione e antibiotico da streptomycescomposizioni farmaceutiche che ad attivita' antibatterica elo contengono.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 365319

Country of ref document: ES